Accent Microcell Limited — PPTs, 16-05-2026: Investor Presentation

Accent Microcell delivered robust financial results for the year and half-year ended March 31, 2026. Full-year FY26 revenue surged 31.92% YoY to ₹349.03 Cr, with PAT growing 32.65% to ₹43.86 Cr. The second half of FY26 showed even stronger growth: revenue at ₹209.67 Cr (up 51.34%) and PAT at ₹25.79 Cr (up 55.40%). Over 63% of revenue comes from exports to 75+ countries, and premium products now account for nearly 87% of sales, highlighting a successful strategic shift.

A key growth driver is the 30% capacity expansion via Unit-III, increasing total capacity to 12,000 MTPA. This new facility will produce high-margin excipients like Croscarmellose Sodium, Carboxymethylcellulose, and Sodium Starch Glycolate, aiming at regulated markets including Europe and contributing an estimated ₹70 Cr in revenue in its first year. Management plans global expansion, focusing on value-added products and exploring new applications in cosmetics, beverages, and other diverse segments.